Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cereno Scientific selects prevention of thrombosis as target indication for its candidate drug CS014

Cereno Scientific (XSAT: CRNO B) today announced that the company’s preclinical drug candidate CS014 will continue toward clinical development for thrombosis prevention. CS014, a novel HDAC inhibitor with epigenetic effects, has, in preclinical studies, demonstrated anti-thrombotic properties supporting the selection of target indications with the aim of preventing thrombosis. The drug candidate is currently in the final stages of its preclinical development program, and a Phase I study is expected to start in 2024.“CS014 has demonstrated promising anti-thrombotic properties in its ongoing

Prostatype Genomics presents Quarterly- & Year End Report

Prostatype Genomics AB has today published its quarterly report for the fourth quarter comprising the period from 1 October 2022 to 31 December 2022, and the year end report for the financial year 2022. The report is available on the company website.Quarter 4 (1 October – 31 December 2022) summarized · Net sales amounted to 304 (0) TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -7 673 (-5 712) TSEK. · Cash flow from current operations in the quarter amounted -7 850 (-5 381) TSEK. · Total cash flow for the period amounted to – 7 950

Nilar International AB Year-end Report 2022

Nilar continues to execute on revised strategyOctober – December 2022 in summary · Net sales, MSEK 1.5 (-0.1). · Delivered batteries 20 (228). · Gross profit MSEK -43.2 (-237.7). · EBITDA1 MSEK -57.0 (-110.6). · Operating profit (EBIT) MSEK -73.3 (-269.5). · Profit for the period MSEK -81.6 (-251.5). · Earnings per share before/after dilution SEK -0.26 (-1.75). January - December 2022 in summary · Net sales MSEK 0.3 (17.8). · Delivered batteries 592 (3 187). · Gross profit MSEK -150.3 (-479.5). · EBITDA MSEK -185.8 (-382.1). · Operating profit (

Navamedic ASA: Q4 2022 financial results

Oslo, 16 February 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces its results for the fourth quarter of 2022. In the period, Navamedic delivered another quarter with solid growth across its portfolio, resulting in a 29 per cent increase in revenues to NOK 116.0 million compared to the same quarter in 2021. For the full year of 2022, revenues amounted to NOK 382.1 million, up 37 per cent compared to 2021.“The fourth quarter completed an eventful year for Navamedic. Product launches,

Lytix Biopharma presents fourth quarter and second half 2022 results

Oslo, 16 February 2023. Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company, today releases its fourth quarter and second half 2022 results – Steady progress towards improving cancer treatment outcomes.“Our molecules have a unique dual mode of action and can kill cancer cells in a way that activates a broad T-cell response that has the potential to target all cancer cells within heterogeneous tumors and thereby increase the number of patients responding to immunotherapy. We have seen very promising effects in cancer patients and are now eagerly

IRRAS AB publishes Year End Report for the period January to December 2022

Commercial partnership underway to wrap up meaningful year of growth “Q4 2022 marked the conclusion of a transformational year for IRRAS, and, as we begin the new year, we have created new opportunities that will accelerate our growth toward achieving leadership in the world of neurocritical care.” “The 4th quarter also marked the start of an extremely exciting next phase for the launch of IRRAflow, our lead product, with the announcement of our commercial partnership with Medtronic, the world’s largest medical device company.” Will Martin, CEO of IRRASFourth quarter, October –

Year-end report 1 January – 31 December 2022

Fourth QUARTER (1 October–31 December 2022) · Net sales for the quarter amounted to MSEK 106 (79). · Operating profit before depreciation and amortisation (EBITDA) totalled MSEK 52 (46) before items affecting comparability and MSEK 52 (32) after items affecting comparability. · Operating profit (EBIT) amounted to MSEK 37 (31) before items affecting comparability and MSEK 37 (17) after items affecting comparability. · Profit after tax totalled MSEK 36 (13), corresponding to SEK 0.80 (0.33) per share before and after dilution. · Operating cash flow was MSEK -3 (23) and cash

Metsä Group has revised its strategic sustainability targets

Metsä Group press release 16 February 2023Metsä Group has revised its 2030 sustainability targets as part of the Group’s strategy work. The revision of the targets is a step towards a fossil free and waste-free future that bolsters nature. The company’s climate actions are based on both global climate change mitigation and adapting to it in Finland’s changing climate. Focusing on the most essential sustainability issues, the targets cover all of Metsä Group’s operations and will also affect supply chains. In particular, Metsä Group is working to increase measures improving forests’

Notice to the Annual General Meeting of Terveystalo Plc

Terveystalo Plc, Stock Exchange Release, 16 February 2023 at 9:00 EET   Notice is given to the shareholders of Terveystalo Plc (the "Company") to participate in the Annual General Meeting to be held on Thursday, 23 March 2023 at 3.00 p.m. (EET) in the event center Pikku Finlandia at Karamzininranta 4, 00100 Helsinki, Finland. The reception of participants and the distribution of voting tickets will commence at the meeting venue at 2:00 p.m. (EET).   Shareholders and their proxy representatives may also exercise their voting rights by voting in advance. Instructions for advance

YIT’s Annual Review for 2022 published

YIT Corporation Stock Exchange Release 16 February 2023 at 9:00 a.m.YIT’s Annual Review for 2022 published YIT’s Annual Review for 2022 has been published today on the company’s website. The Annual Review consists of the highlights of 2022, report of the Board of Directors, consolidated financial statements, parent company’s financial statements, corporate governance statement and remuneration report. The report of the Board of Directors contains YIT’s statement of non-financial information. In addition, YIT publishes the Annual Review in accordance with European Single Electronic

Year-end report January-December 2022

Stable finish to the year   Quarter 4, 2022 · Incoming orders amounted to SEK 1,396m (1,352), equivalent to a currency neutral decrease of 6.7 percent compared with the same period last year. · Net sales amounted to SEK 1,515m (1,152), equivalent to currency neutral growth of 20.4 percent compared with the same period last year. · Adjusted EBITA was SEK 161.1m (143.9), giving an adjusted EBITA margin of 10.6 percent (12.5). · Net profit was SEK 90.9m (84.4). · Earnings per share were SEK 2.59 (2.41). · Cash flow from operating activities amounted to SEK 87.8m (159.

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseFebruary 16, 2023, at 9.00 am EETRepurchase of Outokumpu’s own shares On February 15, 2023, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |23,753 |5.3536

The Ship joins Dataloy Partner Program

The Partnership Between Dataloy And The Ship Enables Customers To Streamline And Digitize Port Data CollectionNorway, 16 February 2023 The Ship AS, a leading provider of data collection solutions, and Dataloy, a leading voyage management system, are proud to announce their partnership. Integrating The Ship’s expertise in data collection and Dataloy’s experience in voyage management will provide customers with a comprehensive and streamlined solution for optimizing the collection of voyage, cargo, and laycan data, resulting in a streamlined and efficient port call procedure. · Key

Acroud AB announces impairment charge to Goodwill during the fourth quarter of 2022.

Acroud AB announces an impairment charge of EUR 18 million related to the old assets stemming from Net Gaming’s (former name of Acroud) acquisition of Highlight Media business back in 2016. Management will report the impairment in the 2022 year-end report as an item affecting comparability during the fourth quarter of 2022. The impairment charge does not affect cash flow.The write-down and consequent impairment charge reflect an updated assessment by management of the assets’ expected future earnings. Management regularly assesses expected future earnings in accordance with IAS 36. The

Interim report Q4: Continued growth and very strong cash flow to close out the year

October – December 2022 · Net sales increased with 66 % and amounted to SEK 973 (587) million · Organic growth increased with 20 (16) % · Adjusted EBIT increased with 74 % and amounted to SEK 79 (45) million with a margin of 8.1 (7.7) % · Cash flow from operating activities increased to SEK 195 (46) million · Earnings per share for the period before and after dilution increased to SEK 0.98 (0.16) January – December 2022 · Net sales increased with 77 % and amounted to SEK 3,402 (1,918) million · Organic growth increased with 25 (25) % · Adjusted EBIT increased

Loyal Solutions signs multi-year contract with Emirates

Yet another market leader has selected Loyal Solutions technology and knowhow, to power the next generation loyalty program.Dubai/Copenhagen  February 16. 2023 Emirates Skywards, the loyalty program of Emirates, today signed a multiyear contract with Loyal Solutions, to power the next generation of the successful Skywards program. " We are very proud to add Emirates Skywards to the growing list of world leading brands using our technology, concepts, and know-how to take their loyalty programs to the next level. Having so many global brands trust Loyal Solutions as their partner is

Railcare adopts new financial targets

The Board of Directors of Railcare Group AB has adopted new financial targets for the period up until the end of 2027. The aim is to increase sales by 60 percent over the next five years.Railcare’s updated financial targets are to achieve sales of SEK 800 million by 2027 and to maintain an operating margin of more than 10 percent. - Our position as an innovative, dynamic specialist in the railway sector helps create good opportunities for growth, and these targets are a better reflection of our potential over the next five years, says Mattias Remahl, CEO of Railcare Group. Major

Apetit Plc's Financial Statements Release 1 January to 31 December 2022: Apetit’s Q4 result from continuing operations improved year-on-year

Apetit Plc, Financial Statements Review on 16 February 2023 at 08:30 a.m.Apetit Plc's Financial Statements Release 1 January to 31 December 2022: Apetit’s Q4 result from continuing operations improved year-on-year October–December 2022, continuing operations* · Net sales amounted to EUR 46.6 (40.3) million. EBITDA was EUR 4.5 (2.2) million. Operating profit was EUR 3.0 (0.7) million. Net sales increased due to an active increase in selling prices. · The net sales of Food Solutions were EUR 17.1 (15.6) million and operating profit EUR 1.8 (1.9) million. Price increases were

NCC to construct 213 residential units in Järva Krog

NCC has been commissioned by Aros Bostad to build 213 rental apartments in Järva Krog adjacent to NCC’s head office in Stockholm. The project is a turnkey contract in partnering form with an order value of approximately SEK 400 million. Image: Hermansson Hiller Lundberg Arkitekter NCC and Aros will now initiate the next stage of the development of Järva Krog by partnering to construct 213 new rental apartments in the Femöringen project. “Femöringen is the second project in Järva Krog in Solna that will be produced together with NCC. We are pleased to be able to start the

Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck

AQILION AB (“Aqilion”) today announced an exclusive license and strategic research collaboration with Merck to discover, develop and commercialize small molecule inhibitors of the transforming growth factor-β-activated kinase 1 (TAK1) protein. Merck will make an upfront cash payment of EUR 10 million to Aqilion. In addition, Aqilion is eligible to receive potential development and commercialization milestones up to over EUR 950 million and tiered royalties on worldwide net sales.The collaboration builds on Aqilion's extensive experience and know-how in the discovery of selective TAK1

Year-end report 2022

High growth and good profitabilityOctober – December 2022 · Net sales increased by 35.6 percent and amounted to SEK 3,590 (2,648) million. Organic growth, adjusted for currency effects, amounted to 10.7 (7.0) percent. · EBITA increased by 28.9 percent and amounted to SEK 292 (227) million. · The EBITA margin was 8.1 (8.6) percent. · The EBITA margin strengthened to 8.1 (7.7) percent, not excluding items affecting comparability of SEK 22 million from last year, which was related to the lump sum payment from AFA Försäkring. · Depreciation/amortisation of property, plant and

Borr Drilling Limited Announces Fourth Quarter and Full Year 2022 Preliminary Results

Hamilton, Bermuda, February 16, 2023: Borr Drilling Limited (“Borr”, “Borr Drilling” or the “Company”) announces preliminary unaudited results for the three and twelve months ended December 31, 2022. Highlights Fourth Quarter of 2022 · Total operating revenues of $148.6 million, an increase of $40.7 million or 38% compared to the third quarter of 2022. · Net loss of $21.3 million, a decrease in loss of $33.6 million compared to the third quarter of 2022. · Cash and cash equivalents of $108.0 million at the end of the fourth quarter of 2022. · Adjusted EBITDA of $55.1

Inside information: DNV Announces a Voluntary Recommended Public Cash Tender Offer for all Shares and Stock Options in Nixu

Nixu Corporation, Stock exchange release, February 16, 2023, 8.30 a.m. EET, Inside InformationNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THIS TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. DNV, the global quality assurance and risk management provider, announces an offer to acquire all issued and outstanding shares and stock options in the cyber security services company Nixu through a voluntary public cash tender offer

There are no items matching the current filter
There are no more items matching the current filter
Back to top